Driving Health Innovation: Harnessing the Power and Value of Real-World Evidence
October 21 – 22, 2019
MaRS Discovery District
101 College Street Toronto, Ontario
Slides
Keynote – Beyond the 1%: Knowing when and how to use RWD to support medical product approvals and use
session 1 – Privacy, data sharing and access
session 2 – Rare drug reimbursement: Policy solutions to patient access (slides not available)
session 3 – UNTAPPED: Innovative ways to use big data in healthcare
session 4 – A method to the madness: Innovative RWE methods that are changing the game (slides not available)
session 5 – Oral presentation of top-ranked research abstracts
session 6 – Where Real World Evidence (RWE) can be used to support suboptimal evidence across all clinical development phases
session 7 – How Canada’s health and pharmacare programs can leverage real-world data and strategic partnerships to address the challenges and opportunities of an aging population and new health technologies
session 8 – The era of artificial intelligence in healthcare
session 9– RWE to support outcome-based agreements in Canada: A case study using patient support program data
session 10 – The path to the future: updates from the CADTH Core Action Team (CAT) on the progress of RWE in Canada
Abstracts presented at the Conference are available online
J Popul Ther Clin Pharmacol Vol 26(3):e14, 2019
Awards
2019 Kris Schindel Award Recipient, Allan F. Gillman
Best Oral Poster was presented to Brittany Humphries,
Impact of patient-target financial incentives on healthcare costs: A systematic review of randomized controlled trials
Department of Health Research Methods, Evidence, and Impact, McMaster University
Best Poster was presented to Jason Hu,
Baseline Bone Density Testing in Men Starting Androgen Deprivation Therapy for Prostate Cancer
Division of Urology, McGill University